141 related articles for article (PubMed ID: 10066098)
1. Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma.
Roesdi MF; Postma TJ; Hoekstra OS; van Groeningen CJ; Wolbers JG; Heimans JJ
J Neurooncol; 1998 Dec; 40(3):251-5. PubMed ID: 10066098
[TBL] [Abstract][Full Text] [Related]
2. Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma.
Vos MJ; Hoekstra OS; Barkhof F; Berkhof J; Heimans JJ; van Groeningen CJ; Vandertop WP; Slotman BJ; Postma TJ
J Clin Oncol; 2003 Oct; 21(19):3559-65. PubMed ID: 12913097
[TBL] [Abstract][Full Text] [Related]
3. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
4. Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma.
Postma TJ; van Groeningen CJ; Witjes RJ; Weerts JG; Kralendonk JH; Heimans JJ
J Neurooncol; 1998 May; 38(1):69-75. PubMed ID: 9540059
[TBL] [Abstract][Full Text] [Related]
5. Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas.
Vallejos V; Balaña C; Fraile M; Roussos Y; Capellades J; Cuadras P; Ballester R; Ley A; Arellano A; Rosell R
J Neurooncol; 2002 Aug; 59(1):81-90. PubMed ID: 12222842
[TBL] [Abstract][Full Text] [Related]
6. [Role of thallium SPECT for evaluating the effect of maintenance chemotherapy against malignant gliomas].
Nagashima G; Fujimoto T; Suzuki R; Asai J; Chang CW
No Shinkei Geka; 2003 Dec; 31(12):1283-9. PubMed ID: 14719441
[TBL] [Abstract][Full Text] [Related]
7. Quantitative 201Tl SPET imaging in the follow-up of treatment for brain tumour: a sensitive tool for the early identification of response to chemotherapy?
Källén K; Geijer B; Malmström P; Andersson AM; Holtås S; Ryding E; Rosén I
Nucl Med Commun; 2000 Mar; 21(3):259-67. PubMed ID: 10823328
[TBL] [Abstract][Full Text] [Related]
8. Thallium-201SPECT assessment in the detection of recurrences of treated gliomas and ependymomas.
Caresia AP; Castell-Conesa J; Negre M; Mestre A; Cuberas G; Mañes A; Maldonado X
Clin Transl Oncol; 2006 Oct; 8(10):750-4. PubMed ID: 17074674
[TBL] [Abstract][Full Text] [Related]
9. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.
Soffietti R; Rudà R; Bradac GB; Schiffer D
Neurosurgery; 1998 Nov; 43(5):1066-73. PubMed ID: 9802850
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.
Prigent-Le Jeune F; Dubois F; Perez S; Blond S; Steinling M
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):714-9. PubMed ID: 14985865
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
Bouffet E; Mornex F; Jouvet A; Thiesse P; Mertens P; Helfre S; Sindou M; Bret P
Bull Cancer; 1997 Oct; 84(10):951-6. PubMed ID: 9435796
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma.
Vos MJ; Tony BN; Hoekstra OS; Postma TJ; Heimans JJ; Hooft L
Nucl Med Commun; 2007 Jun; 28(6):431-9. PubMed ID: 17460533
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
Gómez-Río M; Rodríguez-Fernández A; Ramos-Font C; López-Ramírez E; Llamas-Elvira JM
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):966-75. PubMed ID: 18172642
[TBL] [Abstract][Full Text] [Related]
14. Relationships Between Dose Intensity, Toxicity, and Outcome in Patients with Oligodendroglial Tumors Treated with the PCV Regimen.
Tabouret E; Reyes-Botero G; Dehais C; Daros M; Barrie M; Matta M; Petrirena G; Autran D; Duran A; Bequet C; Delattre JY; Chinot O
Anticancer Res; 2015 May; 35(5):2901-8. PubMed ID: 25964574
[TBL] [Abstract][Full Text] [Related]
15. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
16. Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors.
Matsunaga S; Shuto T; Takase H; Ohtake M; Tomura N; Tanaka T; Sonoda M
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):47-52. PubMed ID: 22541963
[TBL] [Abstract][Full Text] [Related]
17. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography.
Carvalho PA; Schwartz RB; Alexander E; Garada BM; Zimmerman RE; Loeffler JS; Holman BL
J Neurosurg; 1992 Oct; 77(4):565-70. PubMed ID: 1527616
[TBL] [Abstract][Full Text] [Related]
18. Interobserver variability in the semi-quantitative assessment of 201Tl SPECT in cerebral gliomas.
Tony B; Vos MJ; Berkhof J; Postma TJ; van Lingen A; Heimans JJ; Hoekstra OS
Nucl Med Commun; 2005 Jan; 26(1):45-8. PubMed ID: 15604947
[TBL] [Abstract][Full Text] [Related]
19. Thallium-201 SPECT: the optimal prediction of response in glioma therapy.
Vos MJ; Berkhof J; Postma TJ; Hoekstra OS; Barkhof F; Heimans JJ
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):222-7. PubMed ID: 16193315
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of malignant glioma and metastatic brain tumor by thallium-201 single photon emission computed tomography.
Kojima Y; Kuwana N; Noji M; Tosa J
Neurol Med Chir (Tokyo); 1994 Sep; 34(9):588-92. PubMed ID: 7526248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
